Literature DB >> 3481009

[Pre- and postoperative chemotherapy in bone and soft tissue tumors].

K Höffken1.   

Abstract

Adjuvant chemotherapy is efficacious in Ewing's sarcoma, and in osteosarcoma most data support its beneficial effect. There is evidence to suggest efficacy of adjuvant treatment in high-grade malignant soft tissue sarcomas. Neoadjuvant chemotherapy can be used as prediction for the efficacy of further adjuvant chemotherapy and may facilitate resection in osteosarcoma.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3481009     DOI： 10.1007/BF01297834

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN： 0023-8236


  16 in total

1.  Ewing's sarcoma of bone. Experience with 140 patients.

Authors:  R M Wilkins; D J Pritchard; E O Burgert; K K Unni
Journal:  Cancer       Date:  1986-12-01       Impact factor: 6.860

2.  Amputation and adriamycin in primary osteosarcoma.

Authors:  E P Cortes; J F Holland; J J Wang; L F Sinks; J Blom; H Senn; A Bank; O Glidewell
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

3.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

Authors:  M P Link; A M Goorin; A W Miser; A A Green; C B Pratt; J B Belasco; J Pritchard; J S Malpas; A R Baker; J A Kirkpatrick
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

4.  Perspectives on the role of surgery and radiation therapy in the treatment of soft tissue sarcomas of the extremities.

Authors:  S A Rosenberg; E J Glatstein
Journal:  Semin Oncol       Date:  1981-06       Impact factor: 4.929

5.  Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.

Authors:  G Rosen; M L Murphy; A G Huvos; M Gutierrez; R C Marcove
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

6.  [The Cooperative Ewing Sarcoma Study CESS 81 of the German Pediatric Oncology Society--analysis after 4 years].

Authors:  H Jürgens; V Göbel; J Michaelis; W Ramach; J Ritter; R Sauer; J Treuner; P A Voûte; K Winkler; U Göbel
Journal:  Klin Padiatr       Date:  1985 May-Jun       Impact factor: 1.349

7.  High-grade soft tissue sarcomas of the extremities.

Authors:  D A Potter; T Kinsella; E Glatstein; R Wesley; D E White; C A Seipp; A E Chang; E E Lack; J Costa; S A Rosenberg
Journal:  Cancer       Date:  1986-07-01       Impact factor: 6.860

8.  Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.

Authors:  G Rosen; B Caparros; A G Huvos; C Kosloff; A Nirenberg; A Cacavio; R C Marcove; J M Lane; B Mehta; C Urban
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

9.  Control of primary osteosarcoma with chemotherapy.

Authors:  N Jaffe; R Robertson; Y Takaue; A Cangir; S Wallace; H Carrasco; F Eftekhari; A Ayala; A Wang
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

10.  [Results of cytostatic therapy with cyclophosphamide, vincristine, adriamycin and DTIC (CYVADIC) in localized and metastasized osteosarcoma. A retrospective analysis].

Authors:  E Siemers; S Seeber; K Höffken; C G Schmidt
Journal:  Onkologie       Date:  1980-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.